Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 22, 2018

DrugPatentWatch Database Preview

Ranbaxy Company Profile

« Back to Dashboard

What is the competitive landscape for RANBAXY, and what generic and branded alternatives to RANBAXY drugs are available?

RANBAXY has forty-four approved drugs.

There are seventeen tentative approvals on RANBAXY drugs.

Summary for Ranbaxy

US Patents:	0
Tradenames:	32
Ingredients:	29
NDAs:	44
Patent Litigation for Ranbaxy:	See patent lawsuits for Ranbaxy
PTAB Cases with Ranbaxy as petitioner:	See PTAB cases with Ranbaxy as petitioner

Drugs and US Patents for Ranbaxy

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ranbaxy	CEFACLOR	cefaclor	FOR SUSPENSION;ORAL	064164-001	Oct 2, 1997		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Ranbaxy Labs Ltd	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	076413-001	Jun 18, 2004		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Ranbaxy Labs Ltd	RANICLOR	cefaclor	TABLET, CHEWABLE;ORAL	065092-001	Dec 22, 2003		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Ranbaxy Labs Ltd	ETODOLAC	etodolac	TABLET;ORAL	075226-002	Nov 24, 1998		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Ranbaxy

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ranbaxy	AVENTYL	nortriptyline hydrochloride	SOLUTION;ORAL	014685-001	Approved Prior to Jan 1, 1982	3,922,305	➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter

Chinese Patent Office

Johnson and Johnson

Moodys

Mallinckrodt

Julphar

Deloitte

US Department of Justice

Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.